MYBL2 and lung carcinoma: FOXM1 and MYBL2 motifs were enriched at CENPA, FOXM1, and MYBL2-linked enhancers we found in lung cancer cells (91.8% for a FOXM1 motif, 60.3% for an MYBL2 motif) (S10 Table).